Compare Las Vegas Sands Corp. (LVS) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Las Vegas Sands Corp. vs Koninklijke Philips NV — how do they compare? Las Vegas Sands Corp. trades at $45.5 (market cap $30.36B), while Koninklijke Philips NV trades at $26.77 (market cap $26.19B). The key difference: Las Vegas Sands Corp. is the larger of the two by market cap, and Koninklijke Philips NV pays the higher dividend (3.79%). Which is the better fit depends on your goals.
| LVS | PHG | |
|---|---|---|
Market Cap | $30.36B | $26.19B |
Sector | Consumer Cyclical | Health |
52-Week High | $69.49 | $32.91 |
52-Week Low | $44.78 | $24.54 |
Enterprise Value | $42.75B | $32.46B |
Dividend Yield | 2.4% | 3.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LVS trades at $45.47, showing modest 0.24% daily gains amid bearish technical signals. The company demonstrates strong fundamental performance with consistent earnings beats, including Q1 2026 EPS of $0.91 exceeding expectations by 20%. Revenue growth accelerated to $13.02B in 2025, while maintaining solid profitability with 13.41% net margins. Recent corporate actions include a $0.30 dividend payment and $740M share repurchases in Q1 2026.
Analyst consensus remains strongly bullish with 61% buy ratings and $64.75 price target representing 42% upside. Key risks include high debt levels at 73.15% debt-to-asset ratio and potential regulatory headwinds in gaming markets. The combination of strong earnings momentum, attractive valuation at 16.9 P/E, and positive institutional sentiment supports a constructive outlook despite near-term technical weakness.
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner, Four Seasons Hotel Macao, and Parisian in Macao, and the Marina Bay Sands resort in Singapore. Its Venetian and Palazzo Las Vegas in the U.S. asets were sold to Apollo and VICI for $6.25 billion in 2022. We expect Sands to open a fourth tower in Singapore in 2026. After the sale of its Vegas assets, the company will generate all its EBITDA from Asia, with its casino operations generating the majority of sales.
Read more on LVS →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
